Detalhe da pesquisa
1.
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 420-435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718072
2.
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 108(1): 18-25, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153686
3.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.
Neuroendocrinology
; 105(3): 196-200, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190015
4.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.
Neuroendocrinology
; 105(3): 281-294, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28380493
5.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.
Neuroendocrinology
; 105(3): 266-280, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351033
6.
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
N Engl J Med
; 357(17): 1705-15, 2007 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17960013
7.
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
Breast Cancer Res Treat
; 112(3): 533-43, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18188694
8.
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.
Clin Cancer Res
; 13(13): 3899-905, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17606723
9.
A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
Oncology
; 73(1-2): 9-20, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18334829
10.
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma.
Cancer Chemother Pharmacol
; 80(3): 623-629, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766008
11.
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Lung Cancer
; 53(2): 231-9, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16787687
12.
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
J Clin Oncol
; 21(16): 3016-24, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12837811
13.
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
Lung Cancer
; 85(2): 224-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24888230
14.
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
J Clin Oncol
; 28(19): 3107-14, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516432
15.
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
J Clin Oncol
; 27(8): 1227-34, 2009 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188680